• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单次供者特异性输血后,间接激活的 Treg 允许在 MHC I 错配的情况下对小鼠皮肤移植物产生优势耐受。

Indirectly Activated Treg Allow Dominant Tolerance to Murine Skin-grafts Across an MHC Class I Mismatch After a Single Donor-specific Transfusion.

机构信息

Centre for Kidney Research (CKR), Kids Research Institute (KRI), The Children's Hospital at Westmead (CHW), NSW, Australia.

Centre for Transplant and Renal Research (CTRR), Westmead Institute for Medical Research (WIMR), Westmead, NSW, Australia.

出版信息

Transplantation. 2020 Jul;104(7):1385-1395. doi: 10.1097/TP.0000000000003173.

DOI:10.1097/TP.0000000000003173
PMID:32053573
Abstract

BACKGROUND

Tolerance induced in stringent animal transplant models using donor-specific transfusions (DST) has previously required additional immunological manipulation. Here, we demonstrate a dominant skin-allograft tolerance model induced by a single DST across an major histocompatibility class I mismatch in an unmanipulated B6 host.

METHODS

C57BL/6 (H-2) (B6) mice were injected intravenously with splenocytes from B6.C.H-2 (H-2k) (bm1) or F1 (B6 × bm1) mice before skin transplantation. Mice were transplanted 7 days postinjection with donor (bm1 or F1) and third-party B10.BR (H-2) skin grafts.

RESULTS

B6 hosts acutely rejected skin grafts from B6.C.H-2 (bm1) and F1 (B6 × bm1) mice. A single transfusion of F1 splenocytes into B6 mice without any additional immune modulation led to permanent acceptance of F1 skin grafts. This graft acceptance was associated with persistence of donor cells long-term in vivo. The more rapid removal of DST bm1 cells than F1 cells was reduced by natural killer-cell depletion. Tolerant grafts survived an in vivo challenge with naive splenocytes. Both CD4CD25 and CD4CD25 T cells from F1 DST treated B6 mice suppressed alloproliferation in vitro. Tolerance was associated with expansion of peripheral Foxp3CD4CD25 regulatory T cells (Treg) and increased forkhead box P3 (Foxp3) expression in tolerant grafts. In tolerant mice, Foxp3 Treg arises from the proliferation of indirectly activated natural Foxp3 Treg (nTreg) and depletion of Foxp3 Treg abrogates skin-graft tolerance.

CONCLUSIONS

This study demonstrates that the persistence of transfused semiallogeneic donor cells mismatched at major histocompatibility class I can enhance tolerance to subsequent skin allografts through indirectly expanded nTreg leading to dominant tolerance without additional immunological manipulation.

摘要

背景

在严格的动物移植模型中,通过供体特异性输血(DST)诱导的耐受以前需要额外的免疫操作。在这里,我们在未经处理的 B6 宿主中,通过单次 DST 在主要组织相容性复合体 I 不匹配的情况下,展示了一种单一的皮肤同种异体移植物耐受模型。

方法

C57BL/6(H-2)(B6)小鼠在静脉内注射来自 B6.C.H-2(H-2k)(bm1)或 F1(B6×bm1)小鼠的脾细胞,然后进行皮肤移植。在注射后 7 天,将供体(bm1 或 F1)和第三方 B10.BR(H-2)皮肤移植物移植到小鼠体内。

结果

B6 宿主急性排斥 B6.C.H-2(bm1)和 F1(B6×bm1)小鼠的皮肤移植物。未经任何额外免疫调节,单次输注 F1 脾细胞可导致 F1 皮肤移植物的永久接受。这种移植物接受与供体细胞在体内长期存在有关。通过自然杀伤细胞耗竭,减少了 F1 细胞比 DST bm1 细胞更快的清除。耐受的移植物在体内挑战用幼稚脾细胞时存活下来。来自 F1 DST 处理的 B6 小鼠的 CD4CD25 和 CD4CD25 T 细胞均可在体外抑制同种异体增殖。耐受与外周 Foxp3CD4CD25 调节性 T 细胞(Treg)的扩张和耐受移植物中叉头框 P3(Foxp3)表达的增加有关。在耐受的小鼠中,Foxp3 Treg 来自间接激活的天然 Foxp3 Treg(nTreg)的增殖,Foxp3 Treg 的耗竭可破坏皮肤移植物的耐受性。

结论

本研究表明,主要组织相容性复合体 I 不匹配的输注半同种异体供体细胞的持续存在可以通过间接扩增 nTreg 增强对随后的皮肤同种异体移植物的耐受,从而无需额外的免疫操作即可导致显性耐受。

相似文献

1
Indirectly Activated Treg Allow Dominant Tolerance to Murine Skin-grafts Across an MHC Class I Mismatch After a Single Donor-specific Transfusion.单次供者特异性输血后,间接激活的 Treg 允许在 MHC I 错配的情况下对小鼠皮肤移植物产生优势耐受。
Transplantation. 2020 Jul;104(7):1385-1395. doi: 10.1097/TP.0000000000003173.
2
Role of regulatory T cells in CD47/donor-specific transfusion-induced immune tolerance in skin-heart transplantation mice.调节性T细胞在皮肤-心脏移植小鼠中CD47/供体特异性输血诱导的免疫耐受中的作用
Transpl Infect Dis. 2019 Feb;21(1):e13012. doi: 10.1111/tid.13012. Epub 2018 Nov 9.
3
Mechanism of hyporesponsiveness caused by donor-specific transfusion to allogeneic minor antigens.供体特异性输血导致对同种异体次要抗原低反应性的机制。
Eur Surg Res. 2001 May-Jun;33(3):217-24. doi: 10.1159/000049709.
4
Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cells.移植前输注间充质干细胞可通过产生调节性T细胞延长半同种异体心脏移植的存活时间。
J Immunol. 2008 Sep 15;181(6):3933-46. doi: 10.4049/jimmunol.181.6.3933.
5
Allosuppressor and allohelper T cells in acute and chronic graft-vs.-host disease. II. F1 recipients carrying mutations at H-2K and/or I-A.急性和慢性移植物抗宿主病中的同种抑制性和同种辅助性T细胞。II. 在H-2K和/或I-A携带突变的F1受体。
J Exp Med. 1983 Feb 1;157(2):755-71. doi: 10.1084/jem.157.2.755.
6
Prevention of induction of unresponsiveness to class I antigens by veto activity of donor marrow in cylophosphamide-treated mice.
Transplantation. 1993 Dec;56(6):1473-80. doi: 10.1097/00007890-199312000-00037.
7
CD47 is required for suppression of allograft rejection by donor-specific transfusion.CD47 对于供者特异性输血抑制同种异体移植排斥反应是必需的。
J Immunol. 2010 Apr 1;184(7):3401-7. doi: 10.4049/jimmunol.0901550. Epub 2010 Mar 5.
8
Cytokines affecting CD4(+) T regulatory cells in transplant tolerance. Interleukin-4 does not maintain alloantigen specific CD4(+)CD25(+) Treg.影响移植耐受中 CD4(+)T 调节细胞的细胞因子。白细胞介素-4 不能维持同种抗原特异性 CD4(+)CD25(+)Treg。
Transpl Immunol. 2013 Dec;29(1-4):51-9. doi: 10.1016/j.trim.2013.10.003. Epub 2013 Oct 16.
9
Donor-Specific Regulatory T Cell-Mediated Immune Tolerance in an Intrahepatic Murine Allogeneic Islet Transplantation Model with Short-Term Anti-CD154 mAb Single Treatment.供者特异性调节性 T 细胞介导的免疫耐受在短期抗 CD154mAb 单药治疗的肝内同种异体胰岛移植模型中的作用。
Cell Transplant. 2020 Jan-Dec;29:963689720913876. doi: 10.1177/0963689720913876.
10
CCL22 Prevents Rejection of Mouse Islet Allografts and Induces Donor-Specific Tolerance.CCL22可防止小鼠胰岛同种异体移植排斥反应并诱导供体特异性耐受。
Cell Transplant. 2015;24(10):2143-54. doi: 10.3727/096368914X685249.

引用本文的文献

1
Frontiers and Controversies in De Novo Gastrointestinal Tumors After Organ Transplantation: Current Progress and Future Directions.器官移植后新发胃肠道肿瘤的前沿与争议:当前进展与未来方向
Ann Surg Oncol. 2025 May;32(5):3392-3405. doi: 10.1245/s10434-025-16975-w. Epub 2025 Mar 4.
2
Antigen Specific Regulatory T Cells in Kidney Transplantation and Other Tolerance Settings.抗原特异性调节性 T 细胞在肾移植和其他耐受环境中的作用。
Front Immunol. 2021 Aug 26;12:717594. doi: 10.3389/fimmu.2021.717594. eCollection 2021.